APA (7th ed.) Citation

Nieto‐Cid, M., Garriga‐Baraut, T., Plaza‐Martín, A. M., Tortajada‐Girbés, M., Torres‐Borrego, J., Lozano‐Blasco, J., . . . Navarro‐Morón, J. (2023). Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain. Pediatric Allergy & Immunology, 34(4), 1. https://doi.org/10.1111/pai.13942

Chicago Style (17th ed.) Citation

Nieto‐Cid, María, et al. "Cost‐effectiveness of Omalizumab for the Treatment of Severe Pediatric Allergic Asthma—Results of a Real‐life Study in Spain." Pediatric Allergy & Immunology 34, no. 4 (2023): 1. https://doi.org/10.1111/pai.13942.

MLA (9th ed.) Citation

Nieto‐Cid, María, et al. "Cost‐effectiveness of Omalizumab for the Treatment of Severe Pediatric Allergic Asthma—Results of a Real‐life Study in Spain." Pediatric Allergy & Immunology, vol. 34, no. 4, 2023, p. 1, https://doi.org/10.1111/pai.13942.